SCHEMBL17383293

SCHEMBL17383293

c1ccc(Nc2ccc3sc4ccc5ccccc5c4c3c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.50
▸ HSD17B10 Q99714 4/20 0.50
▸ CYP3A4 P08684 3/20 0.50
▸ HPGD P15428 2/20 0.50
▸ HDAC1 Q13547 2/20 0.46
▸ TSHR P16473 3/20 0.41
▸ ALOX15 P16050 2/20 0.41
▸ TP53 P04637 2/20 0.41
▸ CDC25B P30305 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ MAPT P10636 5/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ AR P10275 1/20 0.40
▸ PTGIR P43119 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ IDO1 P14902 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17383309 0.93 ALDH1A1 (0.42) ALDH1A1HSD17B10CYP3A4HPGDHDAC1
SCHEMBL17383296 0.93 ALDH1A1 (0.42) ALDH1A1HSD17B10CYP3A4HPGDHDAC1
SCHEMBL17383292 0.90 ALDH1A1 (0.41) ALDH1A1HSD17B10CYP3A4HPGDHDAC1
SCHEMBL24279266 0.90 HPGD (0.42) ALDH1A1HSD17B10CYP3A4HPGDHDAC1
SCHEMBL19801867 0.90 ALDH1A1 (0.49) ALDH1A1HSD17B10CYP3A4HPGDHDAC1
SCHEMBL17383305 0.89 ALDH1A1 (0.40) ALDH1A1HSD17B10CYP3A4HPGDHDAC1
SCHEMBL17383151 0.87 ALDH1A1 (0.39) ALDH1A1HSD17B10CYP3A4HPGDHDAC1
SCHEMBL17382700 0.87 ALDH1A1 (0.39) ALDH1A1HSD17B10CYP3A4HPGDHDAC1
SCHEMBL17383295 0.85 ALDH1A1 (0.50) ALDH1A1HSD17B10CYP3A4HPGDTSHR
SCHEMBL21234637 0.85 ALDH1A1 (0.37) ALDH1A1HSD17B10CYP3A4HPGDHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11678577-B2 Organic electronic element comprising compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-13 — — US disclosed
US-11678577-B2 Organic electronic element comprising compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-13 — — US disclosed
US-20220131090-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-04-28 — — US disclosed
US-20210320258-A1 COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2021-10-14 — — US disclosed
US-11063226-B1 Organic electronic element comprising compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2021-07-13 — — US disclosed
WO-2021060723-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2021-04-01 — — WO disclosed
WO-2021034089-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2021-02-25 — — WO disclosed
US-20210028370-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREFOR DUK SAN NEOLUX CO., LTD. (KR) 2021-01-28 — — US disclosed
WO-2020138732-A1 COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC APPARATUS USING SAME 덕산네오룩스 주식회사 2020-07-02 — — WO disclosed
US-10424741-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2019-09-24 — — US disclosed
WO-2017204557-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR 덕산네오룩스 주식회사 2017-11-30 — — WO disclosed
US-20170125689-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-05-04 — — US disclosed
US-20170125689-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-05-04 — — US disclosed
WO-2015194791-A2 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2015-12-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11678577-B2 Organic electronic element comprising compound for organic electronic element and an electronic device thereof ESR1, EML4, OCIAD2 ALDH1A1 757/4885HSD17B10 2398/4885CYP3A4 348/4885
US-20170125689-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF GPX1, OR51E2, OCIAD1 ALDH1A1 436/4885HSD17B10 2482/4885CYP3A4 1437/4885
US-10424741-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof GPX1, OR51E2, OCIAD1 ALDH1A1 436/4885HSD17B10 2482/4885CYP3A4 1437/4885
US-20210028370-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREFOR OR51E2, WEE1, SLC39A11 ALDH1A1 1905/4885HSD17B10 3183/4885CYP3A4 2114/4885
US-20210320258-A1 COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, OR10J3, OCIAD1 ALDH1A1 1148/4885HSD17B10 2894/4885CYP3A4 1264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback